About us

FACTS (Fraternity of Advanced Cardiovascular Techniques and Solutions) Foundation - is a non profit organisation formed by like minded group of Cardiologists and some Cardiac Surgeons who irrespective of the area, country , continent they belong are committed to do newer research, innovation, education and training to all physicians and surgeons involved in caring of lives of suffering cardiac patients. It also aims to innovate new modalities of prevention or disease modification of cardiac disorders.
This Foundation unlike any other existing Societies does not believe in having any regional or country restrictions for membership and encourages physicians and surgeons spread all over the world to become members, to exchange new ideas and work towards fast development of new modalities of therapy for patient care.
Ever since its inception in 2009, with idea borne by its Founder Directors- Dr. A. Sreenivas Kumar & Dr. Susheel Kodali, FACTS Foundation has played a major role in realizing dramatic improvements in the accessibility of educative programmes happening all over world to physicians in Hyderabad. FACTS has brought EuroPCR , TCT Live to Hyderabad in 2010 , conducted first ACVS HI 2010 Conference in Hyderabad and was able to attract the visionaries like Dr. Martin Leon, Dr. Eberhard Grube, Prof. Tamburino, etc. & made them look towards Hyderabad & India with a positive approach towards all our Cardiologists. These programmes established o ur interest in showing to the world that we are a group of physicians who are seriously interested for good educative programmes and new innovative procedures which are coming up for the benefit of patient care.

FACTS carries out its mission by following three basic principles Research - Innovation - Education & Training FACTS presently has facilities to reach any part of the world through its websolutions division and conducts regular educative programmes to physicians. FACTS aims at development and distribution of educational materials intended for the global medical community through online journals, CDs, DVDs, Web sites, web casts, and state-of-the-art graphic and multimedia services that include high-definition video production, online interactive training programs, and 3-D modeling and animation. FACTS pledges to develop new opportunities of Fellowship in advanced centers to young and dynamic cardiologists and supports any new research in the form of guidance, funding and helping in providing research services like Angio, Echo, Cardiac MRI & IVUS Core Laboratories. These labs are established at Facts House now with collaboration of Prof. Hans Riber of Leiden University, Medifacts & Netherlands.

This group now with lots of encouragement and support from Columbia University and CVRF wishes to establish the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine. Guided by visionary physicians who are passionate about advancing the field, FACTS is dedicated to discovering and developing innovative therapies to improve the survival and quality of life for those suffering from heart disease around the world. FACTS ’s role in interventional cardiovascular medicine is unique: conducting research on therapies, pharmacology, and devices during the earliest stages of development, confirming safety and efficacy in human clinical trials, and educating the medical community regarding appropriate use of these new procedures and technologies. FACTS is trying to encourage all physicians to develop new modalities of therapy or to refine existing procedures so that they become more operator and patient friendly. To this effect one of our FACTS member Dr. K. Nageshwar Rao along with Founder Director-Dr. A. Sreenivas Kumar has succeeded in developing a newer method- the retrograde approach for device closure of VSDs – a procedure now so simplified so that a novice in interventional cardiology also can confidently practice this form of therapy.
FACTS is working towards patenting new devices for closure of structural heart diseases. FACTS under advice of CVRF aims to accelerate the process of new device development by decreasing the cost of production, hastening up the process of evaluation so as to benefit the suffering patients all over the world.